✦ LIBER ✦

Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study

✍ Scribed by Loredana Miglietta; Luciano Canobbio; Cristina Granetto; Maria Ornella Vannozzi; Mauro Esposito; Francesco Boccardo

Publisher: Springer-Verlag
Year: 1997
Tongue: English
Weight: 444 KB
Volume: 123
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf01240125

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of temozolomide in horm

A phase II study of temozolomide in hormone-refractory prostate cancer

✍ Jérôme P. van Brussel; Martijn B. Busstra; Margreet S. Lang; Tilly Catsburg; Fri 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 71 KB

Phase II study of topotecan in metastati

Phase II study of topotecan in metastatic hormone-refractory prostate cancer

✍ Gary R. Hudes; Richard Kosierowski; Richard Greenberg; Harry E. Ramsey; Stephen 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 562 KB

A phase I/II study of continuous infusio

A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response

✍ C. J. Bowden; W. D. Figg; N. A. Dawson; O. Sartor; R. J. Bitton; M. S. Weinberge 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 156 KB

A phase II study of recombinant human al

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer

✍ Carol M. Van Haelst-Pisani; Ronald L. Richardson; John Su; Jan C. Buckner; Richa 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

To determine the efficacy of recombinant human leukocyte alpha-interferon (IFL-RA) in advanced hormone-refractory prostate cancer, the authors treated 40 patients with IFL-RA administered intramuscularly at a dose of 10 x 10' U/m2 three times weekly. Toxicity was substantial and necessitated at leas

Fixed higher dose schedule of suramin pl

Fixed higher dose schedule of suramin plus hydrocortisone in patients with hormone refractory prostate carcinoma : A multicenter Phase II study

✍ Emiliano Calvo; Javier Cortés; Javier Rodríguez; Manuel Sureda; César Beltrán; J 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

A phase II study of continuous infusion

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

✍ Timothy M. Kuzel; Martin S. Tallman; Daniel Shevrin; Edward Braud; Lary Kilton; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 2 views